ArticleScientific reports2025
Artificial intelligence system for predicting hand-foot skin reaction induced by vascular endothelial growth factor receptor inhibitors.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hand-foot skin reaction (HFSR) is a common adverse effect of vascular endothelial growth factor receptor (VEGFR) inhibitors that significantly impacts patients' quality of life. Prevention and management of HFSR require individualized approaches, but risk factors remain unclear. This study aimed to develop artificial intelligence (AI) models to predict grade ≥ 2 HFSR using clinical data and foot sole images from 93 instances of VEGFR inhibitor administration in 76 patients. Image-based, clinical information-based, and ensemble AI models achieved areas under the curve of 0.550, 0.693, and 0.699, respectively. At a high-specificity cutoff, the ensemble AI had a positive predictive value of 0.824, suggesting potential clinical utility for identifying high-risk patients. Feature importance analysis revealed heavier weight, good performance status, lack of prior VEGFR inhibitor exposure, and baseline skin toxicity as risk factors. These findings represent the first AI-based HFSR prediction models and provide insights for preventive interventions, but further accuracy improvements are needed.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.